Global Acute Pain Management Services Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Acute Pain Management Services market size will reach US$ 1015 million by 2031.
The Acute Pain Service provides care for patients requiring specialised techniques of analgesia, such as Patient Controlled Analgesia (PCA, Opioid Infusions, Epidural Analgesia, and Spinal Analgesia) for acute pain relief on an inpatient basis.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
LPI (LP Information)' newest research report, the “Acute Pain Management Services Industry Forecast” looks at past sales and reviews total world Acute Pain Management Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Acute Pain Management Services sales for 2025 through 2031. With Acute Pain Management Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Pain Management Services industry.
This Insight Report provides a comprehensive analysis of the global Acute Pain Management Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Acute Pain Management Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acute Pain Management Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Pain Management Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Pain Management Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Pain Management Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cancer Pain
Arthritic Pain
Neuropathic Pain
Others
Segmentation by Application:
Hospital
Clinic
Home-use
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Eli Lilly
Pfizer
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche Ltd.
Baxter International Inc.
Purdue Pharma
Endo Pharmaceuticals Plc.
Forest Laboratories Inc.
GlaxoSmithKline Plc.
Please note: The report will take approximately 2 business days to prepare and deliver.
The Acute Pain Service provides care for patients requiring specialised techniques of analgesia, such as Patient Controlled Analgesia (PCA, Opioid Infusions, Epidural Analgesia, and Spinal Analgesia) for acute pain relief on an inpatient basis.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
LPI (LP Information)' newest research report, the “Acute Pain Management Services Industry Forecast” looks at past sales and reviews total world Acute Pain Management Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Acute Pain Management Services sales for 2025 through 2031. With Acute Pain Management Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Pain Management Services industry.
This Insight Report provides a comprehensive analysis of the global Acute Pain Management Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Acute Pain Management Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acute Pain Management Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Pain Management Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Pain Management Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Pain Management Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cancer Pain
Arthritic Pain
Neuropathic Pain
Others
Segmentation by Application:
Hospital
Clinic
Home-use
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Eli Lilly
Pfizer
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche Ltd.
Baxter International Inc.
Purdue Pharma
Endo Pharmaceuticals Plc.
Forest Laboratories Inc.
GlaxoSmithKline Plc.
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
94 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Acute Pain Management Services Market Size by Player
- 4 Acute Pain Management Services by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Acute Pain Management Services Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
